Novosound expands healthcare and wireless ultrasound operations in the US
Novosound enters collaboration with key opinion leader at Baylor College of Medicine, based within the Texas Medical Centre in
Novosound has expanded its healthcare and wireless ultrasound operations in the US.
Dave Hughes-led Novosound has recently entered a wearable ultrasound collaboration with one of America’s leading cardiovascular surgeons, Todd Rosengart, Vice President and DeBakey Bard Chair of Surgery at Baylor College of Medicine, based within the Texas Medical Centre in Houston, Texas, the world’s largest medical centre.
“I have been very impressed with the Novosound technology and how we are applying it to a global clinical need, which we believe will save lives and could indeed become the next vital sign monitor”Dr Rosengert
Rapid growth across three main sectors
CEO and co-founder Dave Hughes said,
“We’re making remarkable progress in the US, venturing into varied sectors such as healthcare, wearables with several clients in the West Coast tech scene, renewables and energy, including an introductory visit to Axiom Space, which closely follows their exciting partnership announcement with the UK Space Agency.”
In addition, the previously announced medical imaging collaborations with NASDAQ-listed PAVmed Inc and dental company dSound continue to progress through significant developmental milestones. Dave Hughes added:
“We’re seeing that our R&D partnerships are frequently translating to commercial agreements, and we expect to
announce a number of these in 2024, particularly in the States.
Novosound is growing rapidly across our three main sectors – medical, wearables, and industrial monitoring, in North America. On the financials, this equates to us doubling revenue for the fourth year in a row, while adding expertise to the team. Overall, we demonstrate that we’re at the forefront of ultrasound sensor technology, and our clients are helping us achieve our vision, which we describe as ‘Ultrasound. Integrated. Everywhere’.
In May, the company appointed former Intel executive David Jolliffe as chief financial officer (CFO), and a series of further appointments have been made in various roles across the business, including in the engineering, sales and marketing teams.